{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:07:24Z","timestamp":1789607244410,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03018-9","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:02:49Z","timestamp":1716562969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Differences between psoriatic arthritis and psoriasis in multi-omics"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3357-4281","authenticated-orcid":false,"given":"Siming","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6410-0596","authenticated-orcid":false,"given":"Hui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"3018_CR1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3899\/jrheum.090218","volume":"83","author":"I Olivieri","year":"2009","unstructured":"Olivieri I, Padula A, D\u2019Angelo S, Cutro MS (2009) Psoriatic arthritis sine psoriasis. J Rheumatol Suppl 83:28\u201329","journal-title":"J Rheumatol Suppl"},{"issue":"Suppl 2","key":"3018_CR2","first-page":"ii14","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14\u201317","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3018_CR3","first-page":"586","volume":"13","author":"DD Gladman","year":"1986","unstructured":"Gladman DD, Anhorn KA, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13(3):586\u2013592","journal-title":"J Rheumatol"},{"issue":"1","key":"3018_CR4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","volume":"71","author":"L Eder","year":"2012","unstructured":"Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD (2012) Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 71(1):50\u201355","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3018_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0019-5154.62751","volume":"55","author":"V Chandran","year":"2010","unstructured":"Chandran V (2010) Genetics of psoriasis and psoriatic arthritis. Indian J Dermatol 55(2):151\u2013156","journal-title":"Indian J Dermatol"},{"issue":"2","key":"3018_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41(2):199\u2013204","journal-title":"Nat Genet"},{"issue":"6","key":"3018_CR7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.1780380619","volume":"38","author":"DD Gladman","year":"1995","unstructured":"Gladman DD, Farewell VT (1995) The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthritis Rheum 38(6):845\u2013850","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3018_CR8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","volume":"17","author":"O FitzGerald","year":"2015","unstructured":"FitzGerald O, Haroon M, Giles JT, Winchester R (2015) Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17(1):115","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3018_CR9","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/1529-0131(199905)42:5<1010::AID-ANR21>3.0.CO;2-H","volume":"42","author":"S Gonzalez","year":"1999","unstructured":"Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Rio J, Rodriguez Perez A, Brautbar C, Lopez-Larrea C (1999) The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 42(5):1010\u20131016","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3018_CR10","first-page":"1449","volume":"35","author":"KC Duffin","year":"2008","unstructured":"Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P (2008) Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 35(7):1449\u20131453","journal-title":"J Rheumatol"},{"issue":"6","key":"3018_CR11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1399-0039.2011.01670.x","volume":"77","author":"R Pollock","year":"2011","unstructured":"Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, Lino M, Shanmugarajah S, Farewell VT, Gladman DD (2011) Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens 77(6):554\u2013561","journal-title":"Tissue Antigens"},{"issue":"6","key":"3018_CR12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","volume":"97","author":"PE Stuart","year":"2015","unstructured":"Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R et al (2015) Genome-Wide Association Analysis of Psoriatic Arthritis and cutaneous psoriasis reveals differences in their Genetic Architecture. Am J Hum Genet 97(6):816\u2013836","journal-title":"Am J Hum Genet"},{"key":"3018_CR13","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","volume":"6","author":"J Bowes","year":"2015","unstructured":"Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J et al (2015) Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun 6:6046","journal-title":"Nat Commun"},{"issue":"11","key":"3018_CR14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.689","volume":"42","author":"E Ellinghaus","year":"2010","unstructured":"Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, Belouchi M, Fournier H, Reinhard C, Ding J et al (2010) Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 42(11):991\u2013995","journal-title":"Nat Genet"},{"issue":"11","key":"3018_CR15","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ng.693","volume":"42","author":"PE Stuart","year":"2010","unstructured":"Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE, Li Y, Weidinger S, Eberlein B, Gieger C et al (2010) Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet 42(11):1000\u20131004","journal-title":"Nat Genet"},{"issue":"12","key":"3018_CR16","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1038\/jid.2009.169","volume":"129","author":"KC Duffin","year":"2009","unstructured":"Duffin KC, Freeny IC, Schrodi SJ, Wong B, Feng BJ, Soltani-Arabshahi R, Rakkhit T, Goldgar DE, Krueger GG (2009) Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 129(12):2777\u20132783","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3018_CR17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/jid.2008.233","volume":"129","author":"U Huffmeier","year":"2009","unstructured":"Huffmeier U, Lascorz J, Bohm B, Lohmann J, Wendler J, Mossner R, Reich K, Traupe H, Kurrat W, Burkhardt H et al (2009) Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 129(2):355\u2013358","journal-title":"J Invest Dermatol"},{"issue":"12","key":"3018_CR18","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1002\/art.24128","volume":"58","author":"C Filer","year":"2008","unstructured":"Filer C, Ho P, Smith RL, Griffiths C, Young HS, Worthington J, Bruce IN, Barton A (2008) Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 58(12):3705\u20133709","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3018_CR19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/jid.2014.414","volume":"135","author":"RA Pollock","year":"2015","unstructured":"Pollock RA, Abji F, Liang K, Chandran V, Pellett FJ, Virtanen C, Gladman DD (2015) Gene expression differences between psoriasis patients with and without inflammatory arthritis. J Invest Dermatol 135(2):620\u2013623","journal-title":"J Invest Dermatol"},{"issue":"12","key":"3018_CR20","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.39800","volume":"68","author":"F Abji","year":"2016","unstructured":"Abji F, Pollock RA, Liang K, Chandran V, Gladman DD (2016) Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis. Arthritis Rheumatol 68(12):2911\u20132916","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"3018_CR21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clinthera.2023.07.003","volume":"45","author":"M Soomro","year":"2023","unstructured":"Soomro M, Hum R, Barton A, Bowes J (2023) Genetic studies investigating susceptibility to psoriatic arthritis: a narrative review. Clin Ther 45(9):810\u2013815","journal-title":"Clin Ther"},{"issue":"11","key":"3018_CR22","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.688","volume":"42","author":"U Huffmeier","year":"2010","unstructured":"Huffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, Juneblad K, Apel M, McManus R, Ho P et al (2010) Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 42(11):996\u2013999","journal-title":"Nat Genet"},{"issue":"4","key":"3018_CR23","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/jid.2011.415","volume":"132","author":"E Ellinghaus","year":"2012","unstructured":"Ellinghaus E, Stuart PE, Ellinghaus D, Nair RP, Debrus S, Raelson JV, Belouchi M, Tejasvi T, Li Y, Tsoi LC et al (2012) Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J Invest Dermatol 132(4):1133\u20131140","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3018_CR24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/rheumatology\/ket296","volume":"53","author":"V Chandran","year":"2014","unstructured":"Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD (2014) Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxford) 53(2):233\u2013239","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3018_CR25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/BOR.0000000000000136","volume":"27","author":"L Eder","year":"2015","unstructured":"Eder L, Chandran V, Gladman DD (2015) What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Curr Opin Rheumatol 27(1):91\u201398","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"3018_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11926-021-01027-5","volume":"23","author":"F Motta","year":"2021","unstructured":"Motta F, Pederzani A, Carena MC, Ceribelli A, Wordsworth PB, De Santis M, Selmi C, Vecellio M (2021) MicroRNAs in Axial Spondylarthritis: an overview of the recent progresses in the Field with a focus on Ankylosing spondylitis and Psoriatic Arthritis. Curr Rheumatol Rep 23(8):59","journal-title":"Curr Rheumatol Rep"},{"key":"3018_CR27","doi-asserted-by":"crossref","unstructured":"Azuaga AB, Ramirez J, Canete JD (2023) Psoriatic arthritis: Pathogenesis and targeted therapies. Int J Mol Sci 24(5)","DOI":"10.3390\/ijms24054901"},{"issue":"1","key":"3018_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/tan.12126","volume":"82","author":"RA Pollock","year":"2013","unstructured":"Pollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, Rahman P, Farewell V, Gladman DD (2013) The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens 82(1):43\u201347","journal-title":"Tissue Antigens"},{"issue":"4","key":"3018_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","volume":"74","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Armstrong AW (2014) Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 74(4):423\u2013441","journal-title":"Drugs"},{"issue":"5","key":"3018_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/03009740410005953","volume":"33","author":"R Queiro-Silva","year":"2004","unstructured":"Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I (2004) The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis. Scand J Rheumatol 33(5):318\u2013322","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"3018_CR31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/ard.2006.064972","volume":"66","author":"PY Ho","year":"2007","unstructured":"Ho PY, Barton A, Worthington J, Thomson W, Silman AJ, Bruce IN (2007) HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis 66(6):807\u2013811","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3018_CR32","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.33415","volume":"64","author":"R Winchester","year":"2012","unstructured":"Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, FitzGerald O (2012) HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 64(4):1134\u20131144","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3018_CR33","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.jaci.2018.11.038","volume":"143","author":"N Dand","year":"2019","unstructured":"Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G et al (2019) HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. J Allergy Clin Immunol 143(6):2120\u20132130","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3018_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdermsci.2022.11.001","volume":"108","author":"M Deng","year":"2022","unstructured":"Deng M, Su Y, Wu R, Li S, Zhu Y, Tang G, Shi X, Zhou T, Zhao M, Lu Q (2022) DNA methylation markers in peripheral blood for psoriatic arthritis. J Dermatol Sci 108(1):39\u201347","journal-title":"J Dermatol Sci"},{"key":"3018_CR35","doi-asserted-by":"crossref","first-page":"1245876","DOI":"10.3389\/fimmu.2023.1245876","volume":"14","author":"V Natoli","year":"2023","unstructured":"Natoli V, Charras A, Hofmann SR, Northey S, Russ S, Schulze F, McCann L, Abraham S, Hedrich CM (2023) DNA methylation patterns in CD4(+) T-cells separate psoriasis patients from healthy controls, and skin psoriasis from psoriatic arthritis. Front Immunol 14:1245876","journal-title":"Front Immunol"},{"key":"3018_CR36","doi-asserted-by":"crossref","first-page":"746145","DOI":"10.3389\/fcell.2021.746145","volume":"9","author":"A Charras","year":"2021","unstructured":"Charras A, Garau J, Hofmann SR, Carlsson E, Cereda C, Russ S, Abraham S, Hedrich CM (2021) DNA methylation patterns in CD8(+) T cells discern Psoriasis from Psoriatic Arthritis and Correlate with Cutaneous Disease Activity. Front Cell Dev Biol 9:746145","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"3018_CR37","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/art.42654","volume":"75","author":"OF Cruz-Correa","year":"2023","unstructured":"Cruz-Correa OF, Pollock RA, Machhar R, Gladman DD (2023) Prediction of psoriatic arthritis in patients with psoriasis using DNA methylation profiles. Arthritis Rheumatol 75(12):2178\u20132184","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"3018_CR38","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1093\/rheumatology\/kead059","volume":"62","author":"J Haschka","year":"2023","unstructured":"Haschka J, Simon D, Bayat S, Messner Z, Kampylafka E, Fagni F, Skalicky S, Hackl M, Resch H, Zwerina J et al (2023) Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis. Rheumatology (Oxford) 62(10):3448\u20133458","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3018_CR39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ced\/llac108","volume":"48","author":"LJ Born","year":"2023","unstructured":"Born LJ, Khachemoune A (2023) Extracellular vesicles: a comprehensive review of their roles as biomarkers and potential therapeutics in psoriasis and psoriatic arthritis. Clin Exp Dermatol 48(4):310\u2013318","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"3018_CR40","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.16203","volume":"34","author":"L Pasquali","year":"2020","unstructured":"Pasquali L, Svedbom A, Srivastava A, Rosen E, Lindqvist U, Stahle M, Pivarcsi A, Sonkoly E (2020) Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis. J Eur Acad Dermatol Venereol 34(6):1248\u20131256","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"3018_CR41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/rheumatology\/kead195","volume":"63","author":"H Johnsson","year":"2024","unstructured":"Johnsson H, Cole J, McInnes IB, Graham G, Siebert S (2024) Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis. Rheumatology (Oxford) 63(1):218\u2013225","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"3018_CR42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjd.21627","volume":"187","author":"R Ramessur","year":"2022","unstructured":"Ramessur R, Corbett M, Marshall D, Acencio ML, Barbosa IA, Dand N, Di Meglio P, Haddad S, Jensen AHM, Koopmann W et al (2022) Biomarkers of disease progression in people with psoriasis: a scoping review. Br J Dermatol 187(4):481\u2013493","journal-title":"Br J Dermatol"},{"issue":"3","key":"3018_CR43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.23298","volume":"70","author":"D Cretu","year":"2018","unstructured":"Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V (2018) Differentiating Psoriatic Arthritis from Psoriasis without Psoriatic Arthritis using Novel serum biomarkers. Arthritis Care Res (Hoboken) 70(3):454\u2013461","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"3018_CR44","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/rheumatology\/keq105","volume":"49","author":"V Chandran","year":"2010","unstructured":"Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, Rosen CF, Gladman DD (2010) Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) 49(7):1399\u20131405","journal-title":"Rheumatology (Oxford)"},{"key":"3018_CR45","doi-asserted-by":"crossref","first-page":"1229516","DOI":"10.3389\/fimmu.2023.1229516","volume":"14","author":"P Ruscitti","year":"2023","unstructured":"Ruscitti P, Esposito M, Di Cola I, Pellegrini C, De Berardinis A, Mastrangelo M, Gianneramo C, Barile A, Fargnoli MC, Cipriani P (2023) Cytokine profile characterization of naive patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum. Front Immunol 14:1229516","journal-title":"Front Immunol"},{"issue":"3","key":"3018_CR46","first-page":"574","volume":"41","author":"S Holm Nielsen","year":"2023","unstructured":"Holm Nielsen S, Magee C, Groen SS, Sinkeviciute D, Bay-Jensen AC, Karsdal MA, Pennington SR, FitzGerald O (2023) Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkers. Clin Exp Rheumatol 41(3):574\u2013580","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3018_CR47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1559-0275-11-27","volume":"11","author":"D Cretu","year":"2014","unstructured":"Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V (2014) Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteom 11(1):27","journal-title":"Clin Proteom"},{"issue":"1","key":"3018_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1559-0275-12-1","volume":"12","author":"D Cretu","year":"2015","unstructured":"Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V (2015) Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteom 12(1):1","journal-title":"Clin Proteom"},{"issue":"2","key":"3018_CR49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2021.03.006","volume":"102","author":"T Kishikawa","year":"2021","unstructured":"Kishikawa T, Arase N, Tsuji S, Maeda Y, Nii T, Hirata J, Suzuki K, Yamamoto K, Masuda T, Ogawa K et al (2021) Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes. J Dermatol Sci 102(2):78\u201384","journal-title":"J Dermatol Sci"},{"key":"3018_CR50","doi-asserted-by":"crossref","unstructured":"Ambrozewicz E, Wojcik P, Wronski A, Luczaj W, Jastrzab A, Zarkovic N, Skrzydlewska E (2018) Pathophysiological alterations of Redox Signaling and Endocannabinoid System in Granulocytes and plasma of psoriatic patients. Cells 7(10)","DOI":"10.3390\/cells7100159"},{"issue":"1","key":"3018_CR51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.42288","volume":"75","author":"A Paine","year":"2023","unstructured":"Paine A, Brookes PS, Bhattacharya S, Li D, De La Luz Garcia-Hernandez M, Tausk F, Ritchlin C (2023) Dysregulation of bile acids, lipids, and nucleotides in Psoriatic Arthritis revealed by unbiased profiling of serum metabolites. Arthritis Rheumatol 75(1):53\u201363","journal-title":"Arthritis Rheumatol"},{"key":"3018_CR52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.12688\/f1000research.4709.1","volume":"3","author":"AW Armstrong","year":"2014","unstructured":"Armstrong AW, Wu J, Johnson MA, Grapov D, Azizi B, Dhillon J, Fiehn O (2014) Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res 3:248","journal-title":"F1000Res"},{"issue":"7","key":"3018_CR53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11306-021-01805-3","volume":"17","author":"N Looby","year":"2021","unstructured":"Looby N, Roszkowska A, Reyes-Garces N, Yu M, Baczek T, Kulasingam V, Pawliszyn J, Chandran V (2021) Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry. Metabolomics 17(7):59","journal-title":"Metabolomics"},{"key":"3018_CR54","doi-asserted-by":"crossref","unstructured":"Wojcik P, Biernacki M, Wronski A, Luczaj W, Waeg G, Zarkovic N, Skrzydlewska E (2019) Altered lipid metabolism in blood mononuclear cells of psoriatic patients indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis. Int J Mol Sci 20(17)","DOI":"10.3390\/ijms20174249"},{"issue":"4","key":"3018_CR55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11306-019-1527-0","volume":"15","author":"R Coras","year":"2019","unstructured":"Coras R, Kavanaugh A, Boyd T, Huynh Q, Pedersen B, Armando AM, Dahlberg-Wright S, Marsal S, Jain M, Paravar T et al (2019) Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics 15(4):65","journal-title":"Metabolomics"},{"issue":"3","key":"3018_CR56","first-page":"481","volume":"37","author":"R Coras","year":"2019","unstructured":"Coras R, Kavanaugh A, Boyd T, Huynh D, Lagerborg KA, Xu YJ, Rosenthal SB, Jain M, Guma M (2019) Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis. Clin Exp Rheumatol 37(3):481\u2013484","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3018_CR57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J et al (2022) Microbiota in health and diseases. Signal Transduct Target Ther 7(1):135","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3018_CR58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10067-017-3908-y","volume":"37","author":"F Mahmood","year":"2018","unstructured":"Mahmood F, Coates LC, Helliwell PS (2018) Current concepts and unmet needs in psoriatic arthritis. Clin Rheumatol 37(2):297\u2013305","journal-title":"Clin Rheumatol"},{"issue":"4","key":"3018_CR59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/ard-2022-223389","volume":"82","author":"A Boix-Amoros","year":"2023","unstructured":"Boix-Amoros A, Badri MH, Manasson J, Blank RB, Haberman RH, Neimann AL, Girija PV, Jimenez Hernandez A, Heguy A, Koralov SB et al (2023) Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin. Ann Rheum Dis 82(4):507\u2013514","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3018_CR60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/sji.12329","volume":"82","author":"YM Mosaad","year":"2015","unstructured":"Mosaad YM (2015) Clinical role of Human Leukocyte Antigen in Health and Disease. Scand J Immunol 82(4):283\u2013306","journal-title":"Scand J Immunol"},{"key":"3018_CR61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","volume":"1253","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lu Q, Chang C (2020) Epigenetics in Health and Disease. Adv Exp Med Biol 1253:3\u201355","journal-title":"Adv Exp Med Biol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03018-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03018-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T11:30:19Z","timestamp":1719401419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03018-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3018"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03018-9","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.\u00a0Sources of funding: This work was supported by grants from the National Natural Science Foundation of China (81901668). Beijing Jishuitan Hospital Nova Program (XKXX202112).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}